Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Techne (NASDAQ:TECH – Get Rating) had its price target upped by Robert W. Baird from $99.00 to $100.00 in a report issued on Thursday, The Fly reports. TECH has been the topic of several other reports. StockNews.com upgraded Bio-Techne from a hold rating to a buy rating in a research report on Wednesday, April 26th. […]
Bio-Techne Co. (NASDAQ:TECH – Get Rating) declared a quarterly dividend on Wednesday, May 3rd, Zacks reports. Stockholders of record on Monday, May 15th will be paid a dividend of 0.08 per share by the biotechnology company on Friday, May 26th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.37%. […]
Fox Run Management L.L.C. acquired a new stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 4,658 shares of the biotechnology company’s stock, valued at approximately $386,000. Several other hedge funds and other institutional investors have […]
Geneva Capital Management LLC grew its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 297.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,059,500 shares of the biotechnology company’s stock after purchasing an additional 793,107 shares during the quarter. Bio-Techne […]
S&CO Inc. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,080 shares of the biotechnology company’s stock after acquiring an additional 19,560 shares during the quarter. S&CO Inc.’s holdings in Bio-Techne […]